Evidence map›Paper›PMID 12207829›Full record

ArticleBMC infectious diseases2002

Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes.

Abeltje M Polstra, J Goudsmit, M Cornelissen

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 51 citations in OpenAlex.

  1. RPA-CRISPR/Cas12a mediated isothermal amplification for visual detection ofFrontiers in cellular and infection microbiology · 2023
    Article
  2. Article
  3. Development of a real-time nucleic acid sequence-based amplification assay for the rapid detection of Salmonella spp. from food.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2019
    Article
  4. Review
  5. Molecular beacons: a novel optical diagnostic tool.Archivum immunologiae et therapiae experimentalis · 2013
    Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Abeltje M PolstraDepartment of Human Retrovirology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. a.m.polstra@amc.uva.nl
J Goudsmit
M Cornelissen
Academic Medical Center · NLAmsterdam University Medical Centers · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman herpesvirus-8 (HHV-8) is linked to the pathogenesis of Kaposi's sarcoma (KS), and the HHV-8 DNA load in peripheral blood mononuclear cells (PBMC) is associated with the clinical stage of KS. To examine the expression of HHV-8 in PBMC, four HHV-8 mRNA specific NASBA assays were developed

methodsWe have developed four quantitative nucleic acid sequence-based amplification assays (NASBA-QT) specifically to detect mRNA coding for ORF 73 (latency-associated nuclear antigen, LANA), vGCR (a membrane receptor), vBcl-2 (a viral inhibitor of apoptosis) and vIL-6 (a viral growth factor). The NASBA technique amplifies nucleic acids without thermocycling and mRNA can be amplified in a dsDNA background. A molecular beacon is used during amplification to enable real-time detection of the product. The assays were tested on PBMC samples of two AIDS-KS patients from the Amsterdam Cohort.

resultsFor all four assays, the limit of detection (LOD) of 50 molecules and the limit of quantification (LOQ) of 100 molecules were determined using in vitro transcribed RNA. The linear dynamic range was 50 to 10(7) molecules of HHV-8 mRNA. We found HHV-8 mRNA expression in 9 out of the 10 tested samples.

conclusionThese real-time NASBA assays with beacon detection provide tools for further study of HHV-8 expression in patient material.

Indexed as

Antigens, ViralBasic-Leucine Zipper Transcription FactorsCarrier ProteinsGenes, ViralHerpesvirus 8, HumanHumansInterleukin-6Leukocytes, MononuclearNuclear ProteinsOncogene ProteinsRepressor ProteinsRNA, MessengerRNA, ViralSarcoma, KaposiSelf-Sustained Sequence ReplicationSensitivity and SpecificityAntigens, ViralBasic-Leucine Zipper Transcription FactorsBcl-2 protein, Human herpesvirus 8Carrier ProteinsInterleukin-6K8 protein, Human herpesvirus 8latency-associated nuclear antigenNuclear ProteinsOncogene ProteinsRepressor ProteinsRNA, MessengerRNA, ViralViral ProteinsViral Structural Proteins

Identifiers

PMID12207829
PMCPMC126271
OpenAlexW2164674891

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.